At Moffitt Cancer Center, we believe clinical trials are an essential part of the cancer care continuum. Every day, we improve patient outcomes and quality of life by matching our patients with promising new treatment options, including those available through the immunotherapy clinical trials overseen by our renowned Blood and Marrow Transplant and Cellular Immunotherapy Program. Working diligently in collaboration with cancer centers across the nation, we have achieved many significant research breakthroughs, and we continue to make great progress in our fight against cancer.
Immunotherapy is a very active area of research at Moffitt, and our outstanding scientists and clinicians are continually exploring new ways to design and implement these advanced treatments. While several drugs and cellular immunotherapies are already approved for treating cancer, hundreds more are available to clinical trial participants. For some cancer patients, joining a clinical trial is the best course of action.
Helping our shared patients explore their options
Many cancer patients are unaware that they may have opportunities to benefit from clinical trials. At Moffitt, we are privileged to collaborate with referring physicians, and we are committed to helping you educate your patients about the latest developments in immunotherapy so that they can make the best possible treatment decisions. For information about our research studies that are accepting new patients, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
If you would like to refer a patient to our Blood and Marrow Transplant and Cellular Immunotherapy Program, complete our online form or contact a physician liaison for assistance. While under the care of the multispecialty team at Moffitt, your patient will receive outstanding clinical services and support, and you will receive timely and informative updates on his or her progress.
